Stéphane Champiat

A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study

Roger Sun, Elaine Johanna Limkin, Maria Vakalopoulou et al. · The Lancet Oncology · 2018 · 1.2K citations

Medicine, Immunology, Oncology +17

Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1

Stéphane Champiat, Laurent Dercle, Samy Ammari et al. · Clinical Cancer Research · 2016 · 1.2K citations

Medicine, Oncology, Pharmacology +17

Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy

Roberto Ferrara, Laura Mezquita, Matthieu Texier et al. · JAMA Oncology · 2018 · 738 citations · Full text

Medicine, Oncology, Pharmacology +14

Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab

Camille Hua, Lise Boussemart, Christine Mateus et al. · JAMA Dermatology · 2015 · 650 citations

Medicine, Dermatology, Oncology +17

Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors

Eléonora De Martin, Jean‐Marie Michot, Barbara Papouin et al. · Journal of Hepatology · 2018 · 532 citations

Life Sciences, Immunology, Oncology +16